O[C@@H]1C[C@H]2N3CC[C@@]2(c2cc4c(cc2C3)OCO4)[C@H]2O[C@@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?